Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 0615-8006

6 FDA label images from Ncs Healthcare Of Ky, Llc Dba Vangard Labs · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 0615-8006). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ncs Healthcare Of Ky, Llc Dba Vangard Labs, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical-structure (Atorvastatin Calcium 10mg Apotex 1)

Chemical-structure (Atorvastatin Calcium 10mg Apotex 1)
Chemical structure of Atorvastatin Calcium, showing the molecular arrangement of calcium salt form with detailed atomic and bond representation.*
FDA Label Image

Figure-01 (Atorvastatin Calcium 10mg Apotex 2)

Figure-01 (Atorvastatin Calcium 10mg Apotex 2)
A cumulative incidence line graph comparing Atorvastatin and Placebo over a period of up to 3.5 years. The y-axis represents cumulative incidence percentage, and the x-axis represents years. The graph shows lower incidence with Atorvastatin than Placebo, with a hazard ratio (HR) of 0.64 and a p-value of 0.0005.*
FDA Label Image

Figure-02 (Atorvastatin Calcium 10mg Apotex 3)

Figure-02 (Atorvastatin Calcium 10mg Apotex 3)
A line graph showing cumulative hazard percentage over time (up to 5 years) comparing Atorvastatin and placebo groups. The graph plots time to first primary endpoint with two lines: a solid line for Atorvastatin and a dashed line for Placebo. Hazard ratio and p-value are noted on the graph.*
FDA Label Image

Figure-03 (Atorvastatin Calcium 10mg Apotex 4)

Figure-03 (Atorvastatin Calcium 10mg Apotex 4)
A line graph comparing the cumulative percentage of subjects experiencing a major cardiovascular event over five years for Atorvastatin 10 mg and Atorvastatin 80 mg dosages. The x-axis shows time in years, and the y-axis shows the percentage of subjects. The graph includes a hazard ratio (HR) of 0.78 with confidence intervals and a p-value, indicating statistical analysis between the two dosage groups.*
FDA Label Image

Bingo Card Label (Atorvastatin Calcium 10mg Apotex 5)

Bingo Card Label (Atorvastatin Calcium 10mg Apotex 5)
Atorvastatin Calcium 10 mg film-coated tablet packaging label showing the product name and dosage strength prominently. The label includes lot number 8006, multiple barcodes, quantity of 30 tablets, and storage instructions (20°-25°C). Manufacturer listed as NCS HealthCare of KY, LLC dba Vangard Labs, Glasgow, KY 42141. The label indicates prescription only and institutional use only, with a note about dispensing in a tight container.*
FDA Label Image

Atorvastatin 10mg Unit Dose Label (Atorvastatin Calcium 10mg Apotex 6)

Atorvastatin 10mg Unit Dose Label (Atorvastatin Calcium 10mg Apotex 6)
This image displays multiple identical labels for Atorvastatin Calcium 10 mg tablets USP, film-coated oral tablets. Each label includes the lot number and expiration date placeholders along with a barcode. The product is packaged by Vangard Labs, Glasgow, KY. Two smaller labels at the bottom show additional packaging details including quantity (30 tablets), storage instructions, and manufacturer information by Apotex.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.